...。 3.3抗病毒治疗的适应症根据大量的循证医学研究,并结合不同地区的实际情况,美国、欧洲和亚太地区相继发布了各自的丙型肝炎治疗指南或共识。所有指南或者共识都将获得持续病毒学应答(SVR)作为治疗的目标。并且所有的指南或者共识都认为ALT正常并不代表肝组织学是正常的,也可给与抗病毒治疗。
基于966个网页-相关网页
然而,在携带有危险等位基因的纯合子型人群中,仍有1/3的人获得了持续病毒学应答(sustained virological response,SVR),所以单纯考虑宿主因素并不能解释丙型肝炎抗病毒治疗的疗效,病毒对IFN治疗的影响也同样值得注意。
基于42个网页-相关网页
(弱) 2.3 CKD 患者抗HCV治疗应答的监测 2.3.1建议以持续病毒学应答(sustained viral response,SVR)作为抗病毒治疗取得应答的标准,即抗病毒治疗结束后6个月HCV RNA仍保持清除状态。
基于10个网页-相关网页
获得持续病毒学应答 sustained viral response ; sustained virologic response ; SVR
的持续病毒学应答 sustained viral response ; SVR
等对持续病毒学应答 sustained virologic response ; SVR
即持续病毒学应答 sustained virological response
建议以持续病毒学应答 sustained viral response ; SVR
出现持续的病毒学应答 sustained virologic response ; SVR
持续的病毒学应答 sustained virologic response
持续性病毒学应答 sustained virus response
持续病毒学应答可以降低肝硬化和肝病并发症的发生,降低肝癌(肝细胞性癌)和死亡的发生率。
Sustained virologic response can result in decreased cirrhosis and complications of liver disease, decreased rates of liver cancer (hepatocellular carcinoma), and decreased mortality.
应用三联疗法的患者中,超过70%的患者能够达到持续病毒学应答,同时对难治性基因型患者也能获得很好的疗效。
This will comprise of direct antiviral drugs such as protease inhibitors along with peg-Interferon and ribavirin. This can provide a sustained virological response in over 70% of patients.
这类患者出现持续病毒学应答(SVR)的机率很高——大概是70%到80%,且无治疗的禁忌症,是非常好的治疗对象。
These patients have a high likelihood of SVR (Sustained Virological Response) - probably 70-80% - and in the absence of any contraindications of therapy they are very good candidates.
应用推荐